*
*Polyarteritis nodosa|155441006
*
*
(also
known|36692007
as "Panarteritis nodosa"[1]|155441006
and
"Periarteritis nodosa"[1]|155441006
)
is
a vasculitis of medium & small-sized arteries,|31996006|68438000|255507004|277049003|31996006|337521007|255507004|277049003|31996006|255508009|23081008|277049003|31996006|255508009|337419004|277049003
which
become
swollen|442672001
and
damaged|37782003
from attack|217315002|216299002
by rogue immune cells.|255386009|4421005

Polyarteritis nodosa|155441006
is
also
called
*
*Kussmaul disease|155441006
*
*
or
*
*Kussmaul-Maier disease|155441006
*
*.

Infantile polyarteritis nodosa|75053002
is
a type|261664005
of PAN|389223000
restricted|263856008
to infants.[3]|418119000

Polyarteritis nodosa|155441006
is
a disease|64572001
of unknown cause|261665006|134198009
that
affects|4065008
arteries,|51114001|11527006
the blood vessels|59820001
that
carry|288345009
blood|87612001|119273009
from the heart|80891009|302509004
to organs|410653004
and
tissues.|85756007

A minority|410599005|255606000
of people|125676002
(about 30%
)
diagnosed|439401001
have
an active Hepatitis B infection,|55561003|66071002
and
men|339947000
are
also twice|421832002
as
likely to|2931005
get
the disease|64572001
as women.|224526002

The condition|260905004
affects|4065008
adults more frequently|133936004|70232002
than children|410601007|160499008
and
males more frequently|248153007|70232002
than females.|248152002

Most cases|398241000|413769002
occur|272120004
between the ages|424144002
of 30
and
49.

It
damages|37782003
the tissues|85756007
supplied|425398004
by the affected arteries|247591002|51114001|247591002|11527006|248448006|51114001|248448006|11527006
because
they
don't
receive
enough oxygen|24099007
and
nourishment
without a proper blood supply.|87612001|425398004|119273009|425398004

Polyarteritis nodosa|155441006
is
more common|242762006|72906007
in people|125676002
with hepatitis B infection.[4]|66071002

In this disease,|64572001
symptoms
result|394617004
from ischemic damage|255426005|37782003
to affected organs,|247591002|410653004|248448006|410653004
often|70232002
the skin,|119325001|39937001|181469002
heart,|80891009|302509004
kidneys,|64033007|17373004
and
nervous system.|25087005|278196006

Generalised symptoms|60132005
include|55919000
fever,|386661006
fatigue,|84229001
weakness,|13791008|260407003
loss
of appetite,|33911006
and
weight loss.|89362005

Muscle|91727004
and
joint aches|57676002
are
common.|72906007

The skin|119325001|39937001|181469002
may
show
rashes,|271807003
swelling|423666004|442672001
,
ulcers,|429040005
and
lumps._[citation|300848003
needed|410525008|103325001
_] Palpable purpura|103357000|423902002
and
livedo reticularis|238772004
can
occur|272120004
in some patients.|116154003

Nerve involvement|3057000|248448006|256864008|248448006
may
cause|23981006|134198009
sensory changes|262139008|243326001|262139008|263703002
with numbness,|398026008|44077006
pain,|22253000
burning,|90673000|62404004
and
weakness|13791008|260407003
(peripheral neuropathy|42658009
).

Central nervous system involvement|21483005|248448006|278199004|248448006
may
cause|23981006|134198009
strokes|230690007
or
seizures.|91175000

Kidney involvement|64033007|248448006|17373004|248448006|181414000|248448006
can
produce
varying degrees|246173007
of renal failure,|42399005
such as hypertension,|38341003
edema,|423666004
oliguria|83128009
and
uremia._[citation|44730006
needed|410525008|103325001
_]

Involvement|248448006
of the arteries|51114001|11527006
of the heart|80891009|302509004
may
cause|23981006|134198009
a heart attack,|22298006
heart failure,|84114007|42343007
and
inflammation|257552002
of the sac
around the heart|80891009|302509004
(pericarditis.|3238004

There
are
no specific lab tests|69658003|261904005|269814003|69658003|261904005|272393004
for diagnosing polyarteritis nodosa.|439401001|155441006

Diagnosis|439401001
is
generally
based|418836005
upon the physical examination|5880005
and
a few laboratory|57176003|261904005
studies|110465008|224699009
that
help
to
confirm|59156000
the diagnosis|439401001
:

A patient|116154003
is
said to|66049007
have
polyarteritis nodosa|155441006
if
he
or
she
has
3
of the 10
following|255260001
signs|72670004
known|36692007
as the 1990 ACR
(American College of Rheumatology|224864007|394810000|224864007|45440000
)
[5] criteria|264706000|264605009
:

It
should
be
underlined
that
the 1990 ACR criteria
were
designed
for classification purposes only.|73504009|363675004

Nevertheless
their good discriminatory performances,|20572008
indicated|410535002
by the initial ACR analysis,|884001|272389005|232714002|272389005
suggested
their potential usefulness|30207005
for diagnostic purposes also.|439401001|363675004|261004008|363675004

Subsequent studies|255260001|110465008|255260001|224699009
did
not
confirm|59156000
their diagnostic utility,|439401001|225927009|261004008|225927009
demonstrating
a significant dependence|386134007|255338002
of their discriminant abilities|371150009
on the prevalence
of the various vasculitides|256220008|31996006
in the analyzed populations.|385436007

Recently|6493001
an original study,|19535007|110465008|19535007|224699009
combining|89780004|20909006
the analysis|272389005
of more|242762006
than 100 items
used|394850002
to
describe
patients characteristics|116154003
in a large sample|255509001|123038009
of vasculitides|31996006
with a computer simulation technique|272394005
designed
to
test|269814003|272393004
the potential diagnostic utility|30207005|439401001|225927009|30207005|261004008|225927009
of the various criteria,|256220008
proposed
a set
of eight positively|421825006
or
negatively PAN discriminating items to|389223000|311718005
be
used|394850002
a screening tool|20135006|86967005
for PAN diagnosis|389223000|439401001|389223000
in patients|116154003
suspected|415684004
of systemic vasculitis.[7]|46956008

Treatment|276239002|416118004
involves|248448006
medications to|410942007
suppress|245780008
the immune system,|116003000
including|55919000
high-dose prednisone|261829003|116602009
and
cyclophosphamide.|387420009

In single cases methotrexate|125681006|398241000|387381009|125681006|413769002|387381009|50607009|398241000|387381009|50607009|413769002|387381009
may
be
also helpful [8].

Therapy|276239002
results|394617004
in remissions|277022003
or
cures
in 90%|264705001|264703008
of cases.|398241000|413769002

Untreated|25265005
,
the disease|64572001
is
fatal|399166001
in most cases.|398241000|413769002

The most serious associated conditions generally|4757001|42745003|47429007|260905004
involve|248448006
the kidneys|64033007|17373004
and
gastrointestinal tract.|122865005|279972009

A fatal course usually|399166001|288524001
involves|248448006
gastrointestinal hemorrhage,|74474003
infection,
myocardial infarction|22298006
and/or
renal failure.[9]|42399005

In case|398241000
of remission,|277022003
approximately 60% experience relapse|26175008|263855007|26175008|255318003|26175008|58184002
within five years.|421820001|258707000

In cases|398241000|413769002
caused|23981006|134198009
by hepatitis B virus,|81665004
however,
recurrence rate|246455001
is
only approximately 6%.[11]|50607009|26175008|420295001|26175008

This disease|64572001
cannot
be
currently|15240007
prevented|116699007
,
but
early treatment|264499004|276239002|264499004|416118004
can
prevent
some damage|37782003
and
symptoms._[citation
needed|410525008|103325001
_]

M
:
VAS|273903006

anat(
a
:
h/u/t/a/l,v:h/u/t/a/l/phys/devp/cell/prot|4421005|304383000|362837007|304383000

noco/syva/cong/lyvd/tumr,
sysi/epon,
injr

proc,
drug|410942007
(C2s+n/3/4/5/7/8/9

